Found: 270
Select item for more details and to access through your institution.
Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 8, p. 2013, doi. 10.1093/jac/dks152
- By:
- Publication type:
- Article
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1462
- By:
- Publication type:
- Article
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 1, p. 32, doi. 10.1093/jac/dkr433
- By:
- Publication type:
- Article
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 4, p. 901, doi. 10.1093/jac/dkr006
- By:
- Publication type:
- Article
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 358, doi. 10.1093/jac/dkq432
- By:
- Publication type:
- Article
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 11, p. 2450, doi. 10.1093/jac/dkq332
- By:
- Publication type:
- Article
Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 3, p. 417, doi. 10.1093/jac/dkp482
- By:
- Publication type:
- Article
Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 5, p. 992
- By:
- Publication type:
- Article
A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1374, doi. 10.1093/jac/dkn377
- By:
- Publication type:
- Article
Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 2, p. 400
- By:
- Publication type:
- Article
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 1, p. 206
- By:
- Publication type:
- Article
Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 1, p. 191
- By:
- Publication type:
- Article
Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 60, n. 2, p. 436
- By:
- Publication type:
- Article
Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 6, p. 824, doi. 10.1093/jac/dki142
- By:
- Publication type:
- Article
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad542
- By:
- Publication type:
- Article
Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/4380845
- By:
- Publication type:
- Article
Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17237-5
- By:
- Publication type:
- Article
Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11181-0
- By:
- Publication type:
- Article
Inappropriate sinus tachycardia in post-COVID-19 syndrome.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03831-6
- By:
- Publication type:
- Article
Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?
- Published in:
- Journal of NeuroVirology, 2010, v. 16, n. 3, p. 208, doi. 10.3109/13550281003767710
- By:
- Publication type:
- Article
SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.
- Published in:
- Membranes, 2021, v. 11, n. 1, p. 64, doi. 10.3390/membranes11010064
- By:
- Publication type:
- Article
EOSINOPHILIC PUSTULAR FOLLICULITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME.
- Published in:
- 1992
- By:
- Publication type:
- Report
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Antiretroviral drug resistance testing in adults with HIV infection.
- Published in:
- JAMA: Journal of the American Medical Association, 1998, v. 279, n. 24, p. 1984, doi. 10.1001/jama.279.24.1984
- By:
- Publication type:
- Article
Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19526
- By:
- Publication type:
- Article
Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19490
- By:
- Publication type:
- Article
Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19685
- By:
- Publication type:
- Article
DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19821
- By:
- Publication type:
- Article
Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19609
- By:
- Publication type:
- Article
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19550
- By:
- Publication type:
- Article
Association between lipid genetic and immunological status in chronically HIV-infected patients.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19555
- By:
- Publication type:
- Article
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19557
- By:
- Publication type:
- Article
Natural History of Anal Squamous Intraepithelial Lesions in HIV-Positive Men with Normal Baseline Cytology.
- Published in:
- AIDS Patient Care & STDs, 2019, v. 33, n. 11, p. 459, doi. 10.1089/apc.2019.0186
- By:
- Publication type:
- Article
High Prevalence of Signs of Renal Damage Despite Normal Renal Function in a Cohort of HIV-Infected Patients: Evaluation of Associated Factors.
- Published in:
- AIDS Patient Care & STDs, 2014, v. 28, n. 10, p. 524, doi. 10.1089/apc.2014.0172
- By:
- Publication type:
- Article
Lymphogranuloma Venerium Proctitis in the Setting of HIV: A Case Report and Differential Diagnosis.
- Published in:
- AIDS Patient Care & STDs, 2009, v. 23, n. 7, p. 493, doi. 10.1089/apc.2008.0261
- By:
- Publication type:
- Article
Low Levels of Adherence to Antiretroviral Therapy in HIV-1–Infected Women with Menstrual Disorders.
- Published in:
- AIDS Patient Care & STDs, 2009, v. 23, n. 6, p. 463, doi. 10.1089/apc.2009.0016
- By:
- Publication type:
- Article
Therapeutic Challenge for Isospora belli Enteritis in an AIDS Patient Who Developed Lyell Syndrome after Co-Trimoxazole Therapy.
- Published in:
- 1989
- By:
- Publication type:
- Letter
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 9025, doi. 10.3390/ijms24109025
- By:
- Publication type:
- Article
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 15000, doi. 10.3390/ijms232315000
- By:
- Publication type:
- Article
Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-022-00488-7
- By:
- Publication type:
- Article
Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2089, doi. 10.3390/jcm8122089
- By:
- Publication type:
- Article
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 298, doi. 10.3390/vaccines12030298
- By:
- Publication type:
- Article
A Cost–Benefit Analysis of COVID-19 Vaccination in Catalonia.
- Published in:
- Vaccines, 2022, v. 10, n. 1, p. 59, doi. 10.3390/vaccines10010059
- By:
- Publication type:
- Article
Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection.
- Published in:
- AIDS & Behavior, 2014, v. 18, n. 4, p. 676, doi. 10.1007/s10461-013-0612-z
- By:
- Publication type:
- Article
Author Correction: Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30114-z
- By:
- Publication type:
- Article
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genes.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25719-9
- By:
- Publication type:
- Article
Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18996-x
- By:
- Publication type:
- Article
Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.993401
- By:
- Publication type:
- Article
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1001068
- By:
- Publication type:
- Article